Karuna Therapeutics’ experimental drug, KarXT, is poised to receive FDA approval this month, potentially revolutionizing schizophrenia treatment. This innovative drug could offer relief for millions of Americans battling the debilitating disorder, marking the first significant breakthrough in over 70 years. However, concerns remain about accessibility due to high potential costs and systemic issues in the U.S. healthcare system.